[Effects of alpha-calcidiol (1 alpha-hydroxy-cholecalciferol) on the serum levels of osteocalcin in involutional osteoporosis]. 1989

M Pedrazzoni, and G Ciotti, and L Davoli, and P P Vescovi, and A Ianes, and D Costi, and T Santini, and V Ulietti, and M Passeri

We have examined the effects of 1 alpha-hydroxycolecalciferol (1 alpha) (1.5 micrograms for 5 days) on serum osteocalcin (OC) and other parameters of bone and mineral metabolism in 20 osteoporotic women and 11 age-matched normal women. After 1 alpha administration, a statistically significant (p less than 0.01) increase of serum OC, calcium and phosphate and urinary calcium and hydroxyproline was observed. In contrast, alkaline phosphatase was unchanged. There was no significant difference between normal and osteoporotic women in the changes of any of the parameters we monitored. In particular, OC increased in a comparable way in both groups. Thus, by means of an index that reflects the global activity of the skeleton, we could not find any apparent defect of osteoblastic responsiveness to the drug in osteoporotic subjects.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006887 Hydroxycholecalciferols Hydroxy analogs of vitamin D 3; (CHOLECALCIFEROL); including CALCIFEDIOL; CALCITRIOL; and 24,25-DIHYDROXYVITAMIN D 3. Hydroxyvitamins D,Hydroxycholecalciferol
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015519 Bone Density The amount of mineral per square centimeter of BONE. This is the definition used in clinical practice. Actual bone density would be expressed in grams per milliliter. It is most frequently measured by X-RAY ABSORPTIOMETRY or TOMOGRAPHY, X RAY COMPUTED. Bone density is an important predictor for OSTEOPOROSIS. Bone Mineral Content,Bone Mineral Density,Bone Densities,Bone Mineral Contents,Bone Mineral Densities,Density, Bone,Density, Bone Mineral
D015675 Osteocalcin Vitamin K-dependent calcium-binding protein synthesized by OSTEOBLASTS and found primarily in BONES. Serum osteocalcin measurements provide a noninvasive specific marker of bone metabolism. The protein contains three residues of the amino acid gamma-carboxyglutamic acid (Gla), which, in the presence of CALCIUM, promotes binding to HYDROXYAPATITE and subsequent accumulation in BONE MATRIX. Bone Gla Protein,Calcium-Binding Protein, Vitamin K-Dependent,Gla Protein, Bone,Vitamin K-Dependent Bone Protein,4-Carboxyglutamic Protein, Bone,Bone gamma-Carboxyglutamic Acid Protein,4 Carboxyglutamic Protein, Bone,Bone 4-Carboxyglutamic Protein,Bone gamma Carboxyglutamic Acid Protein,Calcium Binding Protein, Vitamin K Dependent,Protein, Bone 4-Carboxyglutamic,Protein, Bone Gla,Vitamin K Dependent Bone Protein

Related Publications

M Pedrazzoni, and G Ciotti, and L Davoli, and P P Vescovi, and A Ianes, and D Costi, and T Santini, and V Ulietti, and M Passeri
June 1989, Clinical rheumatology,
M Pedrazzoni, and G Ciotti, and L Davoli, and P P Vescovi, and A Ianes, and D Costi, and T Santini, and V Ulietti, and M Passeri
May 2014, Journal of bone and mineral metabolism,
M Pedrazzoni, and G Ciotti, and L Davoli, and P P Vescovi, and A Ianes, and D Costi, and T Santini, and V Ulietti, and M Passeri
January 1991, Acta medica Austriaca,
M Pedrazzoni, and G Ciotti, and L Davoli, and P P Vescovi, and A Ianes, and D Costi, and T Santini, and V Ulietti, and M Passeri
June 1990, European journal of clinical investigation,
M Pedrazzoni, and G Ciotti, and L Davoli, and P P Vescovi, and A Ianes, and D Costi, and T Santini, and V Ulietti, and M Passeri
April 1979, Journal of steroid biochemistry,
M Pedrazzoni, and G Ciotti, and L Davoli, and P P Vescovi, and A Ianes, and D Costi, and T Santini, and V Ulietti, and M Passeri
October 1978, The Biochemical journal,
M Pedrazzoni, and G Ciotti, and L Davoli, and P P Vescovi, and A Ianes, and D Costi, and T Santini, and V Ulietti, and M Passeri
April 1999, Calcified tissue international,
M Pedrazzoni, and G Ciotti, and L Davoli, and P P Vescovi, and A Ianes, and D Costi, and T Santini, and V Ulietti, and M Passeri
December 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
M Pedrazzoni, and G Ciotti, and L Davoli, and P P Vescovi, and A Ianes, and D Costi, and T Santini, and V Ulietti, and M Passeri
February 2006, Bone,
M Pedrazzoni, and G Ciotti, and L Davoli, and P P Vescovi, and A Ianes, and D Costi, and T Santini, and V Ulietti, and M Passeri
September 1991, Bone and mineral,
Copied contents to your clipboard!